Advertisement
ORAL PRESENTATIONS Poster Session – Saturday, April 2 08d: VIRAL HEPATITIS C: CLINICAL (NEW COMPOUNDS, RESISTANCE)| Volume 54, SUPPLEMENT 1, S475-S476, March 01, 2011

1204 PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS